Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

106.94 +0.66 (+0.62%)
Streaming Delayed Price Updated: 10:11 AM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions
From Agilent Technologies Inc.
Via Business Wire
Why Quality Investors Should Delve into AGILENT TECHNOLOGIES INC (NYSE:A) for Investment Opportunities.
Is NYSE:A a Suitable Choice for Quality Investing? 
Via Chartmill
Agilent to Participate in Jefferies Global Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
Via Benzinga
How Is The Market Feeling About Agilent Technologies?
Via Benzinga
Agilent Presents Solutions Innovation Research Awards to Cornell and Indiana University Researchers
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29
From Agilent Technologies Inc.
Via Business Wire
Padraig McDonnell Assumes Agilent CEO Role
From Agilent Technologies Inc.
Via Business Wire
(A) - Analyzing Agilent Technologies's Short Interest
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,100 Today
Via Benzinga
Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
From Agilent Technologies Inc.
Via Business Wire
Agilent Names Simon May to Lead Diagnostics and Genomics Group
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives Scientists' Choice Awards for Sustainability
From Agilent Technologies Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Via Benzinga
A Glimpse Into The Expert Outlook On Agilent Technologies Through 6 Analysts
Via Benzinga
Inquiry Into Agilent Technologies's Competitor Dynamics In Life Sciences Tools &amp; Services Industry
Via Benzinga
Looking Into Agilent Technologies's Recent Short Interest
Via Benzinga
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
From Agilent Technologies Inc.
Via Business Wire
Agilent Brings Great Science to Life at Analytica 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
From Agilent Technologies Inc.
Via Business Wire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today
Via Benzinga
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
From Agilent Technologies Inc.
Via Business Wire
Nvidia, Broadcom Lead AI Charge: BofA Analyst Tips AMD, Micron as Emerging Contenders in Explosive Market Growth
BofA Securities analyst Vivek Arya’s top picks were Nvidia Corp (NASDAQ:NVDA) (Buy, price target of $1,100) and Broadcom Inc (NASDAQ:A 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
From Agilent Technologies Inc.
Via Business Wire
Agilent, Shoe Carnival And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan
From Agilent Technologies Inc.
Via Business Wire
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback